Video Latest - ecancer

The optimal approach after neoadjuvant treatment: The Lucerne toolbox

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal

3 Feb 2022

Tumour agnostic treatments in GI cancer

Dr Nicola Normanno and Dr Katja Schmitz

1 Feb 2022

OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO

Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Franco & Dr Kathleen Schemeler

19 Jan 2022

OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more

Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla Karim, Dr Fumiko Chino, Dr Narjust Duma & Dr Nicole Kuderer

19 Jan 2022

OncoAlert Colloquium Day 4: GI oncology and EONS

Dr Cathy Eng, Dr Yelena Janjigian, Ms Stacy Hurt, Ms Allison Rosen, Dr Mark Lewis, Dr Nina Niu Sanford, Mr Johan de Munter & Dr Merel Van Klinken

19 Jan 2022

OncoAlert Colloquium Day 3: Breast cancer

Dr Erika Hamilton, Dr Bhawna Sirohi, Ms Ginny Mason RN, Dr Hope Rugo, Dr Sara Tolaney, Dr Matteo Lambertini & Dr Icro Meattini

19 Jan 2022

OncoAlert Colloquium Day 2: Lung cancer and MASCC

Dr Stephen Liu, Dr Jack West, Dr Sanay Popat, Dr Jarushka Naidoo, Dr Percy Lee, Ms Jill Feldman, Ms Ivy Elkins, Dr Andrew Davies & Dr Joanne Bowen

19 Jan 2022

OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology

Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean McBride, Dr Ravindran Kanesvaran & Dr Nicolo Battisti

19 Jan 2022

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic

Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand

15 Dec 2021

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients

Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands

14 Dec 2021

Integrated genomic analysis identifies UBTF tandem duplications as a subtype-defining lesion in paediatric AML

Dr Masayuki Umeda - St. Jude Children's Research Hospital, San Francisco, USA

14 Dec 2021

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diffuse large B-cell lymphoma.

Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy

11 Dec 2021

Video